EDGAR Filing Documents for 0001683168-18-003538

Form 8-K - Current report:

SEC Accession No. 0001683168-18-003538

Filing Date

2018-11-21

Accepted

2018-11-21 16:00:27

Documents

Period of Report

2018-11-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	sonoma_8k.htm	8-K	31926
2	SONOMA PHARMACEUTICALS, INC.	sonoma_8k-ex0301.htm	EX-3.1	104338
3		sonoma_8k-ex0302.htm	EX-3.2	13099
4	SERIES C COMMON STOCK WARRANT CERTIFICATE	sonoma_8k-ex0401.htm	EX-4.1	123404
5	FORM OF UNIT PURCHASE OPTION	sonoma_8k-ex0402.htm	EX-4.2	75827
6	PLACEMENT AGENCY AGREEMENT	sonoma_8k-ex1001.htm	EX-10.1	216565
7	WARRANT AGENCY AGREEMENT	sonoma_8k-ex1002.htm	EX-10.2	245142
	Complete submission text file	0001683168-18-003538.txt		811671

Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954

Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550

Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)